title: 31P-MR spectroscopy in human end-stage heart failure during therapy with recombinant human growth hormone.
authors.affiliation: 2nd Medical Clinic, University Hospital, Mainz, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Wittlinger
authors.forename: T
authors.initials: T
authors.lastname: Voigtländer
authors.forename: K F
authors.initials: KF
authors.lastname: Kreitner
authors.forename: P
authors.initials: P
authors.lastname: Kalden
authors.forename: S
authors.initials: S
authors.lastname: Genth-Zotz
authors.forename: H
authors.initials: H
authors.lastname: Darius
authors.forename: M
authors.initials: M
authors.lastname: Thelen
authors.forename: J
authors.initials: J
authors.lastname: Meyer
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D001706:Biopsy; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D013006:Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D019906:Nuclear Magnetic Resonance, Biomolecular / Q000379:methods; D010725:Phosphocreatine / Q000378:metabolism; D015203:Reproducibility of Results
chemical_list: D010725:Phosphocreatine; D000255:Adenosine Triphosphate; D013006:Growth Hormone